Clinton Larry Stinchcomb

Insider

First SEC filing: June 1, 2026 · Latest: June 1, 2026

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.
Compensation Executive pay disclosed in company proxy statements.

Insider at

CURI buying May 28, 2026

Insider transactions

3 buys (P) 0 sells (S) Net: $409,929 + 21 non-open-market transactions below Avg return of open purchases vs now: 7.9% last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

21 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
May 28, 2026	CURI	P	25,744	$2.78	$71,568	2,971,260 Direct	+0.87%	Acquired	5.9% (price as of 2026-08-20)
May 27, 2026	CURI	P	94,256	$2.74	$258,261	2,945,516 Direct	+3.31%	Acquired	7.5% (price as of 2026-08-20)
May 26, 2026	CURI	P	30,000	$2.67	$80,100	2,851,260 Direct	+1.06%	Acquired	10.3% (price as of 2026-08-20)
Aug. 31, 2023	CURI	F	7,698	$1.05	$8,083	151,809 Direct	-4.83%	Disposed	180.5% (price as of 2026-08-20)
Aug. 2, 2023	CURI	M	31,610	—	—	360,487 Direct	-8.06%	Disposed	(price as of 2026-08-20)
Aug. 2, 2023	CURI	M	31,610	—	—	159,507 Direct	+24.72%	Acquired	(price as of 2026-08-20)
July 28, 2023	CURI	D	355,500	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
July 28, 2023	CURI	D	2,038,570	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
July 28, 2023	CURI	D	618,561	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
July 28, 2023	CURI	D	16,067	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
July 28, 2023	CURI	D	315,593	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
July 28, 2023	CURI	A	392,097	—	—	392,097 Direct	—	Acquired	(price as of 2026-08-20)
July 28, 2023	CURI	A	692,887	—	—	692,887 Direct	—	Acquired	(price as of 2026-08-20)
Nov. 9, 2022	CURI	F	8,683	$1.22	$10,593	127,897 Direct	-6.36%	Disposed	141.4% (price as of 2026-08-20)
Nov. 9, 2022	CURI	F	6,193	$1.22	$7,555	136,580 Direct	-4.34%	Disposed	141.4% (price as of 2026-08-20)
Nov. 9, 2022	CURI	F	1,035	$1.22	$1,263	142,773 Direct	-0.72%	Disposed	141.4% (price as of 2026-08-20)
Nov. 5, 2021	CURI	F	17,913	$9.40	$168,382	143,808 Direct	-11.08%	Disposed	-68.7% (price as of 2026-08-20)
Nov. 5, 2020	CURI	A	73,458	—	—	161,721 Direct	+83.23%	Acquired	(price as of 2026-08-20)
Nov. 5, 2020	CURI	A	88,263	—	—	88,263 Direct	—	Acquired	(price as of 2026-08-20)
Nov. 2, 2020	CURI	A	2,038,570	—	—	2,038,570 Direct	—	Acquired	(price as of 2026-08-20)
Nov. 2, 2020	CURI	A	355,500	—	—	355,500 Direct	—	Acquired	(price as of 2026-08-20)
Oct. 14, 2020	CURI	A	315,593	—	—	315,593 Direct	—	Acquired	(price as of 2026-08-20)
Oct. 14, 2020	CURI	A	16,067	—	—	16,067 Direct	—	Acquired	(price as of 2026-08-20)
Oct. 14, 2020	CURI	A	618,561	—	—	618,561 Direct	—	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Aug. 2, 2023	CURI	Restricted Stock Units	Common Stock (31,610)	—	—	31,610	Disposed
July 28, 2023	CURI	Stock Options (right to buy)	Common Stock (355,500)	$11.50	—	355,500	Disposed
July 28, 2023	CURI	Stock Options (right to buy)	Common Stock (2,038,570)	$8.77	—	2,038,570	Disposed
July 28, 2023	CURI	Stock Options (right to buy)	Common Stock (618,561)	$4.04	—	618,561	Disposed
July 28, 2023	CURI	Stock Options (right to buy)	Common Stock (16,067)	$4.04	—	16,067	Disposed
July 28, 2023	CURI	Stock Options (right to buy)	Common Stock (315,593)	$4.20	—	315,593	Disposed
July 28, 2023	CURI	Restricted Stock Units	Common Stock (392,097)	—	—	392,097	Acquired
July 28, 2023	CURI	Restricted Stock Units	Common Stock (692,887)	—	—	692,887	Acquired
Nov. 2, 2020	CURI	Stock Option (right to buy)	Common Stock (2,038,570)	$8.77	Nov. 2, 2030	2,038,570	Acquired
Nov. 2, 2020	CURI	Stock Option (right to buy)	Common Stock (355,500)	$11.50	Nov. 2, 2025	355,500	Acquired
Oct. 14, 2020	CURI	Stock Option (right to buy)	Common Stock (315,593)	$4.20	Aug. 1, 2029	315,593	Acquired
Oct. 14, 2020	CURI	Stock Option (right to buy)	Common Stock (16,067)	$4.04	Jan. 29, 2029	16,067	Acquired
Oct. 14, 2020	CURI	Stock Option (right to buy)	Common Stock (618,561)	$4.04	Nov. 19, 2028	618,561	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CURI

President & CEO

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2025	$717,081	—	$9,468,000	—	$2,400,000	—	$18,807	$12,603,888
2024	$677,014	—	$4,136,100	—	$782,128	—	$13,200	$5,608,442
2023	$619,500	—	$1,106,684	—	$108,446	—	$13,200	$1,847,830

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.